Atrium gets FDA clearance for PRKAG2 syndrome trial
Atrium, a biotech company, got permission from the FDA to start testing a new treatment for PRKAG2 syndrome. This rare genetic disorder affects many people worldwide. The new treatment is a type of surgery called PRKAG2.
5.5Significance
1 source5.0Source trust